Wednesday, Nov. 24, 2021 Oral Probiotic Bacillus Prevents Enterococcal Sepsis in Mouse Study NIAID intramural scientists have shared an unexpected finding in their continuing study of a common probiotic digestive supplement, Bacillus bacteria, as a treatment for bacterial gut infections. Bacillus given orally stopped colonizing pathogenic Enterococcus faecalis from spreading into the bloodstream and causing a system-wide infection known as sepsis. The study, published in Science Translational Medicine, builds on research from 2018 where the same group discovered that people with Bacillus in their gut never were colonized with a different bacterium, Staphylococcus aureus, which has a similar sensing mechanism as E. faecalis. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107